Pharma Penny Stock At Rs 65 Enters Into An Mou With Vaibhav Kashinath Chaudhari & Mistycube Analytics To Enter French West African Market

Kiran Shroff
Pharma Penny Stock At Rs 65 Enters Into An Mou With Vaibhav Kashinath Chaudhari & Mistycube Analytics To Enter French West African Market

The company has a market cap of Rs 76 crore and as of September 27, 2024, the stock is trading at Rs 65 per share on NSE.

Medicamen Organics Limited (MOL) expands its global footprint with a strategic partnership in the French West African (FWA) market.

Through its newly formed subsidiary, Grande Etoile Pharmaceuticals Ltd. (GEPL), MOL has entered into a Memorandum of Understanding (MoU) with Vaibhav Kashinath Chaudhari (VKC) and Mistycube Analytics (MA). This collaboration aims to establish a strong presence in the FWA region, including countries like Senegal, Mali, and Ivory Coast. MOL will hold a controlling 51% stake in GEPL, while VKC and MA will contribute their expertise and local market knowledge.

The partnership will focus on creating a robust infrastructure and distribution network to support the growth of GEPL in the FWA market. By registering its products in these regions and potentially sourcing additional products from other manufacturers, MOL aims to capitalize on the growing demand for pharmaceutical products in this region. This strategic move aligns with MOL's broader vision of expanding its global reach and providing essential healthcare solutions to diverse markets.

DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.

About the Company

Medicamen Organics Limited (MOL) is a leading Indian pharmaceutical company specializing in the production and distribution of a diverse range of healthcare products. With a global presence, MOL is dedicated to innovation and quality in its offerings. Their extensive product portfolio includes essential medications for various ailments, such as antibacterial, antifungal, and antidiabetic drugs. MOL's commitment to accessibility is evident in its distribution network, reaching customers across India and in regions like Africa, the Commonwealth of Independent States (CIS), and Southeast Asia. The company has a market cap of Rs 76 crore and as of September 27, 2024, the stock is trading at Rs 65 per share on NSE.  

Disclaimer: The article is for informational purposes only and not investment advice. 

Rate this article:
4.3

Leave a comment

Add comment

DSIJ MINDSHARE

Mkt Commentary4-Oct, 2024

Bonus and Spilt Shares5-Oct, 2024

Multibaggers5-Oct, 2024

Multibaggers5-Oct, 2024

Multibaggers5-Oct, 2024

Knowledge

General20-Sep, 2024

General19-Sep, 2024

Technical18-Sep, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR